Dongkook Pharmaceutical Co Ltd (086450)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Dongkook Pharmaceutical Co Ltd (086450) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014387
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Dongkook Pharmaceutical Co Ltd (Dongkook) formerly known as UEC & Co. Ltd, is a pharmaceutical company which develops, manufacture and distributes pharmaceutical products, health care products and medical devices. It offers pharmaceutical products such as antibiotics, anodynes, vitamins, wound care ointments, injections, anti diabetes agents, generics, formulations, anticancer medicines and circulatory system agents among others. The company provides remedies for oral troubles, skin troubles and gynecology diseases, contrast mediums, anesthetics, diabetes among others. Dongkook’s medical devices include ballast injection, ballast soft injection, pare surgical and medical components. The company conducts research and development to develop new products. It operates through a factory located in Jincheon-gun. Dongkook is headquartered in Seoul, South Korea.

Dongkook Pharmaceutical Co Ltd (086450) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Dongkook Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Dongkook Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Dongkook Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Dongkook Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Dongkook Pharmaceutical Co Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Dongkook Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Dongkook Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Probi Enters Into Distribution Agreement With Dongkook Pharma 11
Equity Offering 12
DongKook Pharma Announces Public Offering Of Shares For US$1.6 Million 12
Acquisition 13
National Pension Service Acquires 5.09% Stake In Dongkook Pharma 13
Truston Asset Management Acquires 5.39% Stake In DongKook Pharma 14
Korea Value Asset Management Divests 8.78% Stake In DongKook Pharma 15
Tozai Holdings Acquires 27.9% Stake In DongKoo Pharma 16
Dongkook Pharmaceutical Co Ltd – Key Competitors 17
Dongkook Pharmaceutical Co Ltd – Key Employees 18
Dongkook Pharmaceutical Co Ltd – Locations And Subsidiaries 19
Head Office 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Dongkook Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Dongkook Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Dongkook Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Dongkook Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Dongkook Pharmaceutical Co Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Dongkook Pharmaceutical Co Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Dongkook Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Probi Enters Into Distribution Agreement With Dongkook Pharma 11
DongKook Pharma Announces Public Offering Of Shares For US$1.6 Million 12
National Pension Service Acquires 5.09% Stake In Dongkook Pharma 13
Truston Asset Management Acquires 5.39% Stake In DongKook Pharma 14
Korea Value Asset Management Divests 8.78% Stake In DongKook Pharma 15
Tozai Holdings Acquires 27.9% Stake In DongKoo Pharma 16
Dongkook Pharmaceutical Co Ltd, Key Competitors 17
Dongkook Pharmaceutical Co Ltd, Key Employees 18

★海外企業調査レポート[Dongkook Pharmaceutical Co Ltd (086450)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Casio Computer Co., Ltd.:企業の戦略・SWOT・財務分析
    Casio Computer Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Casio Computer Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Genuine Parts Company:企業の戦略・SWOT・財務分析
    Genuine Parts Company - Strategy, SWOT and Corporate Finance Report Summary Genuine Parts Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Vaccinex Inc (VCNX):製薬・医療:M&Aディール及び事業提携情報
    Summary Vaccinex Inc (Vaccinex) is a clinical-stage biotechnology company that discovers and develops targeted biotherapeutics to treat neurodegenerative diseases, cancer and autoimmune disorders. The company’s lead platform technologies include antibody platform and ActivMAb, SEMA4D, and antibody d …
  • Vermilion Energy Inc (VET):石油・ガス:M&Aディール及び事業提携情報
    Summary Vermilion Energy Inc (Vermilion) is an oil and gas company that offers exploration and production services. The company is an oil and gas producer in Alberta. It offers production programs focusing on acquisition, exploration, development and optimization in North America, Europe and Austral …
  • Roquette Freres SA:企業の戦略的SWOT分析
    Roquette Freres SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • The PNC Financial Services Group Inc:戦略・SWOT・企業財務分析
    The PNC Financial Services Group Inc - Strategy, SWOT and Corporate Finance Report Summary The PNC Financial Services Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Svenska Cellulosa Aktiebolaget:企業のM&A・事業提携・投資動向
    Svenska Cellulosa Aktiebolaget - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Svenska Cellulosa Aktiebolaget Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Taiwan Liposome Co Ltd (4152):企業の財務・戦略的SWOT分析
    Summary Taiwan Liposome Co Ltd (TLC) is a clinical-stage pharmaceutical company, which develops and commercializes novel nanomedicines based on drug delivery technology platform. The company’s pipeline products include TLC599, TLC590, TLC399 and TLC178. Its TLC 178 is used for the treatment of adult …
  • Goldman Sachs Group Inc:戦略・SWOT・企業財務分析
    Goldman Sachs Group Inc - Strategy, SWOT and Corporate Finance Report Summary Goldman Sachs Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Archer Ltd (ARCHER):石油・ガス:M&Aディール及び事業提携情報
    Summary Archer Ltd (Archer) is an oilfield services company. It provides drilling services, well integrity and intervention, plug and abandonment and decommissioning. Its drilling and work-over services include platform drilling, land drilling, modular rigs, drilling fluids, solids control, engineer …
  • Denison Mines Corp (DNN):企業の財務・戦略的SWOT分析
    Denison Mines Corp (DNN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Enerjisa Enerji Uretim AS:企業の戦略的SWOT分析
    Enerjisa Enerji Uretim AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Malayan Flour Mills Berhad:企業の戦略・SWOT・財務分析
    Malayan Flour Mills Berhad - Strategy, SWOT and Corporate Finance Report Summary Malayan Flour Mills Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Titan Petrochemicals Group Limited (1192):石油・ガス:M&Aディール及び事業提携情報
    Summary Titan Petrochemicals Group Limited (Titan) is an investment holding company that carries out midstream energy and shipbuilding operations. It provides oil storage, transit, and blending services. The company transports oil and petrochemical products; and supplies oil products. Titan also car …
  • Bank Muscat:企業の戦略・SWOT・財務分析
    Bank Muscat - Strategy, SWOT and Corporate Finance Report Summary Bank Muscat - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Vestel Elektronik Sanayi Ve Ticaret AS:企業の戦略・SWOT・財務分析
    Vestel Elektronik Sanayi Ve Ticaret AS - Strategy, SWOT and Corporate Finance Report Summary Vestel Elektronik Sanayi Ve Ticaret AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Bta Bank Jsc
    Bta Bank Jsc - Strategy, SWOT and Corporate Finance Report Summary Bta Bank Jsc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • China International Travel Service Corporation Limited:企業の戦略・SWOT・財務分析
    China International Travel Service Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary China International Travel Service Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company' …
  • Medrobotics Corp:製品パイプライン分析
    Summary Medrobotics Corp (Medrobotics), formerly Cardioborobotics Inc is a medical device company that develops flexible robot platforms for single-site surgical and interventional applications. The company provides flex robotic systems and flex retractor systems. Its flexible robot platform contain …
  • Molnlycke Health Care AB:医療機器:M&Aディール及び事業提携情報
    Summary Molnlycke Health Care AB (Molnlycke), a subsidiary of Investor AB, is a medical device company. The company manufactures and markets single-use surgical and wound care products. It offers a range of surgical and wound care products; infection prevention solutions; prevention and treatment so …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆